A detailed history of Wpg Advisers, LLC transactions in Geron Corp stock. As of the latest transaction made, Wpg Advisers, LLC holds 42 shares of GERN stock, worth $59. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42
Holding current value
$59
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$1.59 - $3.6 $66 - $151
42 New
42 $67,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $537M
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Wpg Advisers, LLC Portfolio

Follow Wpg Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wpg Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wpg Advisers, LLC with notifications on news.